- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UOS: 1-[4-(5-chloropyrazin-2-yl)piperazin-1-yl]-2-[4-(propan-2-yl)phenyl]ethan-1-one(Non-covalent)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
ANP.2: 23 residues within 4Å:- Chain A: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Chain B: I.261
- Ligands: UOS.1, MG.3, EDO.4
25 PLIP interactions:25 interactions with chain A- Hydrogen bonds: A:G.28, A:T.29, A:L.30, A:L.30, A:K.32, A:G.199, A:S.200, A:S.200, A:G.201, A:G.223, A:E.240, A:N.330, A:N.330, A:F.331, A:R.333
- Water bridges: A:K.32, A:E.146, A:E.146, A:N.197, A:N.197, A:N.197, A:G.199, A:R.333
- Salt bridges: A:K.32
- pi-Stacking: A:F.239
ANP.8: 23 residues within 4Å:- Chain A: I.261
- Chain B: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, L.227, F.239, E.240, G.329, N.330, F.331, R.333
- Ligands: UOS.7, MG.9, EDO.10
26 PLIP interactions:26 interactions with chain B- Hydrogen bonds: B:G.28, B:T.29, B:L.30, B:L.30, B:K.32, B:G.199, B:S.200, B:S.200, B:G.201, B:G.223, B:E.240, B:N.330, B:N.330, B:F.331, B:R.333
- Water bridges: B:T.29, B:K.32, B:E.146, B:E.146, B:N.197, B:N.197, B:N.197, B:G.199, B:R.333
- Salt bridges: B:K.32
- pi-Stacking: B:F.239
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 7 residues within 4Å:- Chain A: L.30, T.69, I.71, R.94, F.95, P.96
- Ligands: ANP.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.94
EDO.5: 6 residues within 4Å:- Chain A: I.284, R.289
- Chain B: L.227, S.231, C.236, E.237
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:E.237, A:K.286, A:R.289, A:R.289
EDO.10: 7 residues within 4Å:- Chain B: L.30, T.69, I.71, R.94, F.95, P.96
- Ligands: ANP.8
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.94
EDO.11: 6 residues within 4Å:- Chain A: L.227, S.231, C.236, E.237
- Chain B: I.284, R.289
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:E.237, A:E.237, B:K.286, B:R.289, B:R.289
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, L.K. et al., LipE guided discovery of isopropylphenyl pyridazines as pantothenate kinase modulators. Bioorg.Med.Chem. (2021)
- Release Date
- 2021-11-24
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x UOS: 1-[4-(5-chloropyrazin-2-yl)piperazin-1-yl]-2-[4-(propan-2-yl)phenyl]ethan-1-one(Non-covalent)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sharma, L.K. et al., LipE guided discovery of isopropylphenyl pyridazines as pantothenate kinase modulators. Bioorg.Med.Chem. (2021)
- Release Date
- 2021-11-24
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A